Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Alexis Geoffroy

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Current Medicinal Chemistry|December 15, 2021
Sleep Markers in Psychiatry: Do Insomnia and Disturbed Sleep Play as Markers of Disrupted Neuroplasticity in Mood Disorders? A Proposed ModelLaura Palagini, Pierre Alexis Geoffroy, Dieter Riemann
Journal of Psychiatric Research|May 22, 2025
Weather's influence on the number of emergency psychiatric visits: myth or reality? A systematic review of the literatureMarion N'Diambourila, Pierre Alexis Geoffroy, Marine Ambar Akkaoui
CNS Neuroscience & Therapeutics|October 26, 2012
Combination therapy for manic phases: a critical review of a common practicePierre Alexis Geoffroy, Bruno Etain, Chantal Henry, et al.
Expert Opinion on Therapeutic Targets|March 3, 2015
Sleep- and circadian rhythm-associated pathways as therapeutic targets in bipolar disorderFrank Bellivier, Pierre-Alexis Geoffroy, Bruno Etain, et al.
Clinical Neuropharmacology|May 16, 2013
Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individualsBenjamin Rolland, Pierre Alexis Geoffroy, Renaud Jardri, et al.
Current Pharmaceutical Design|December 15, 2015
Bipolar Disorder: The Role of the Kynurenine and Melatonergic PathwaysGeorge Anderson, Aude Jacob, Frank Bellivier, et al.
Handbook of Clinical Neurology|January 26, 2025
Circadian aspects in nonpharmacologic and pharmacologic treatment of insomniaLaura Palagini, Pierre-Alexis Geoffroy, Raffaele Manni, et al.
CNS Neuroscience & Therapeutics|April 11, 2012
Efficacy of aripiprazole in comorbid addiction in bipolar disorderPierre Alexis Geoffroy, Guillaume Goddefroy, Benjamin Rolland, et al.
Psychiatry Research|February 1, 2014
Somatotopy and bodily hallucinationsPierre Alexis Geoffroy, Vincent Laprevote, Pierre Thomas, et al.
Frontiers in Bioscience (Elite Edition)|January 7, 2014
Can the response to mood stabilizers be predicted in bipolar disorder?Pierre Alexis Geoffroy, Frank Bellivier, Marion Leboyer, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Current Medicinal Chemistry|December 15, 2021
Sleep Markers in Psychiatry: Do Insomnia and Disturbed Sleep Play as Markers of Disrupted Neuroplasticity in Mood Disorders? A Proposed ModelLaura Palagini, Pierre Alexis Geoffroy, Dieter Riemann
Journal of Psychiatric Research|May 22, 2025
Weather's influence on the number of emergency psychiatric visits: myth or reality? A systematic review of the literatureMarion N'Diambourila, Pierre Alexis Geoffroy, Marine Ambar Akkaoui
CNS Neuroscience & Therapeutics|October 26, 2012
Combination therapy for manic phases: a critical review of a common practicePierre Alexis Geoffroy, Bruno Etain, Chantal Henry, et al.
Expert Opinion on Therapeutic Targets|March 3, 2015
Sleep- and circadian rhythm-associated pathways as therapeutic targets in bipolar disorderFrank Bellivier, Pierre-Alexis Geoffroy, Bruno Etain, et al.
Clinical Neuropharmacology|May 16, 2013
Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individualsBenjamin Rolland, Pierre Alexis Geoffroy, Renaud Jardri, et al.
Current Pharmaceutical Design|December 15, 2015
Bipolar Disorder: The Role of the Kynurenine and Melatonergic PathwaysGeorge Anderson, Aude Jacob, Frank Bellivier, et al.
Handbook of Clinical Neurology|January 26, 2025
Circadian aspects in nonpharmacologic and pharmacologic treatment of insomniaLaura Palagini, Pierre-Alexis Geoffroy, Raffaele Manni, et al.
CNS Neuroscience & Therapeutics|April 11, 2012
Efficacy of aripiprazole in comorbid addiction in bipolar disorderPierre Alexis Geoffroy, Guillaume Goddefroy, Benjamin Rolland, et al.
Psychiatry Research|February 1, 2014
Somatotopy and bodily hallucinationsPierre Alexis Geoffroy, Vincent Laprevote, Pierre Thomas, et al.
Frontiers in Bioscience (Elite Edition)|January 7, 2014
Can the response to mood stabilizers be predicted in bipolar disorder?Pierre Alexis Geoffroy, Frank Bellivier, Marion Leboyer, et al.
Pageof 11